HT
MRNS

HAP Trading’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

HAP Trading’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-150,000
Closed -$274K – 1149
2023
Q4 		$274K Sell
150,000
-100,000
-40% -$749K 0.04% 256
2023
Q3 		$118K Buy
250,000
+150,000
+150% +$1.25M 0.02% 369
2023
Q2 		$123K Buy
+100,000
New +$856K 0.02% 354
2020
Q3 		– Sell
-4,750
Closed -$4K – 1979
2020
Q2 		$4K Buy
+4,750
New +$43.7K ﹤0.01% 1579
2019
Q4 		– Sell
-4,375
Closed -$3K – 1537
2019
Q3 		$3K Buy
+4,375
New +$35.3K ﹤0.01% 1167

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HAP Trading's MRNS Position: Q3 2018 in Review

HAP Trading sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2018, closing a stake of 54,366 shares — an estimated $1.55M sold.

HAP Trading first reported a position in MRNS in Q1 2018 and held it in 2 quarters. The position peaked at $1.54M in Q2 2018. 96 funds tracked by Wall St. Rank hold MRNS as of Q3 2018.

  • HAP Trading reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2018 after selling out during the quarter.
  • HAP Trading sold 54,366 Marinus Pharmaceuticals, Inc shares in Q3 2018, an estimated $1.55M.
  • HAP Trading first reported a position in Marinus Pharmaceuticals, Inc in Q1 2018 and held it in 2 quarters.
  • HAP Trading's Marinus Pharmaceuticals, Inc position peaked at $1.54M in Q2 2018.
  • 96 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2018.

Based on HAP Trading's 13F filing for Q3 2018, filed 9 Nov 2018.